The emergence of new technologies is disrupting the health sector where digital is at the heart of the revolution. It is the bearer of a strong ambition to invent an effective response to the challenges of the sector and accelerate the shift towards so-called “5P” medicine: personalized, preventive, predictive, participative and evidence-based. This digital transformation in health must be carried out for the benefit of the general population and patients.
Emerging infectious diseases – CBRN threats
The Covid-19 pandemic illustrates the major impacts that the emergence of new pathogens can have even beyond the health issue. The MIE-MN (Emerging Infectious Diseases and Nuclear, Radiological, Biological and Chemical Threats) acceleration strategy aims to enable the State to understand, prevent and control the emergence or re-emergence of infectious diseases.
Biotherapy and bioproduction innovative therapies
The strategy promotes the emergence of new technologies as well as the scaling up of existing technologies in order to reduce the cost of access to these new therapeutic products. In the long term, it is a question of increasing French sovereignty in terms of health.
Example of current calls for projects :